Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 7/20 | 0.40 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.33 |
| ▸ | RELA | Q04206 | 2/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.30 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18577923 | 0.81 | ESR1 (0.45) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| SCHEMBL21066301 | 0.80 | LMNA (0.42) | ESR1FDFT1SMN1; SMN2NPC1NFKB1 | |
| SCHEMBL18577898 | 0.79 | RAB9A (0.46) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| SCHEMBL18577902 | 0.75 | ESR1 (0.58) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| SCHEMBL517954 | 0.74 | ESR1 (0.68) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| SCHEMBL31176947 | 0.71 | ESR1 (0.65) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| SCHEMBL9772833 | 0.71 | ESR1 (0.65) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| Phosphine SCHEMBL15190577 | 0.71 | ESR1 (0.65) | ESR1ESR2NPSR1SMN1; SMN2GAA | |
| SCHEMBL4780784 | 0.69 | ESR1 (0.64) | ESR1ESR2NPSR1HTT | |
| SCHEMBL30930597 | 0.69 | NPC1 (0.57) | SMN1; SMN2NPC1NFKB1RAB9ANFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9997722-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-06-12 | — | — | US | disclosed |
| US-20170069849-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170069849-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ELOVL1, L1CAM, CRY1 | ESR1 13/4885ESR2 102/4885NPSR1 4195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.